HGH (10 IU (3.33 mg))
Recombinant 191-amino acid Somatropin (rhGH, 10 IU) verified for native sequence identity, dual disulfide folding, and low dimer/aggregate content (<1.0% via SEC-HPLC) for JAK2–STAT5 and IGF-1 pathway research.
Scientific Profile & Research Key Points: HGH
Recombinant 191-amino acid Somatropin (rhGH, 10 IU) verified for native sequence identity, dual disulfide folding, and low dimer/aggregate content (<1.0% via SEC-HPLC) for JAK2–STAT5 and IGF-1 pathway research.
Active Batch Release Specifications (Lot SL-2026-132)
Analytical release verification for current HGH (10 IU (3.33 mg)) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-132 | 2026-10-28 | SEC-HPLC + SDS-PAGE (Reducing & Non-Reducing) | ≥99.0% (Monomeric Purity) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL); trickle down glass wall, NEVER shake
Temperature & Stability
Store lyophilized at 2°C–8°C; refrigerate reconstituted solution at 2°C–8°C (never freeze reconstituted protein).
HGH — Technical Questions & Answers
Why is HGH analyzed by SEC-HPLC and SDS-PAGE instead of standard small-peptide RP-HPLC alone?
At 22,124 Da (191-aa polypeptide), recombinant proteins like HGH possess tertiary and quaternary folding structures that denature under harsh reversed-phase organic gradients. Size-exclusion chromatography (SEC-HPLC) and SDS-PAGE verify monomeric integrity and detect dimers or aggregates.
How do researchers minimize adsorption and aggregation when preparing HGH (10 IU (3.33 mg))?
Avoid vigorous vortexing, foaming, or repeated freeze-thaw cycles. Slowly introduce buffer along the borosilicate vial wall and consider low-protein-binding polypropylene tubes (or carrier protein buffer where assay-compatible) for nanomolar working dilutions.
What biological receptor system is HGH used to probe in vitro?
HGH (CAS 12629-01-5) targets Growth Hormone Receptor (GHR) / JAK2–STAT5 signaling (Lyophilized sterile glycine/mannitol phosphate cake). Reference publication: Waters M.J., Nat Rev Endocrinol (2016) — Growth hormone receptor JAK2–STAT5 activation mechanisms (PMID: 26670782).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
CJC-1295, Ipamorelin, and Sermorelin: GHRH Analogues vs Ghrelin Receptor Agonists
A deep dive into somatotropic axis stimulation. Comparing GHRH receptor binding, DAC modification kinetics, ghrelin/GHS-R1a agonism, and pulsatile growth hormone secretion.
Gonadorelin, HCG, HMG and Kisspeptin: Mapping the Hypothalamic-Pituitary-Gonadal Axis
A comparative map of the HPG axis: GnRH receptor agonism (Gonadorelin), LH receptor mimetics (HCG), combined FSH/LH activity (HMG), and upstream GPR54 activation (Kisspeptin-10).
Human Growth Hormone (191aa): Somatropin Structure, Isoforms, and SEC-HPLC Analysis
A deep analysis of authentic 191-amino acid Somatropin vs 192-amino acid Somatrem. Size-exclusion chromatography (SEC), deamidation artifacts, and mass confirmation.
Related GH Secretagogues & Growth Factors Compounds
View category →